08/09/2026
We are delighted to announce an exciting new collaboration between Polar BloodMove and Swedish MedTech company Tridentify, bringing together innovative blood transportation and intelligent monitoring technology to help support safer, more efficient blood logistics.
The two companies will be exhibiting together at the British Blood Transfusion Society (BBTS) Annual Conference 2026, taking place in Glasgow from Tuesday 15th to Thursday 17th September 2026.
Smarter Blood Transportation
At Polar BloodMove, our focus is on providing reliable temperature-controlled solutions designed specifically for the transportation of blood and blood components.
Our BloodMove range has been developed to support healthcare organisations, blood services and laboratories with dependable solutions for moving these vital products through the cold chain.
Our collaboration with Tridentify takes this a step further by combining specialist blood transportation with intelligent, individual-level monitoring.
Introducing Tridentify’s QTA Tracer System®
Tridentify is a Swedish MedTech company. Tridentify's QTA Tracer System® is a patented, sensor-based system designed to monitor temperature-sensitive products including blood, plasma and other transfusion components throughout their journey. Tridentify's QTA Tracer System® is the first and only temperature monitoring medical solution with shelf-life management worldwide to receive CE-marking according to MDR specifically indicated for transfusion medicine and blood products, under European Union’s rigorous Medical Device Regulation (EU 2017/745). It enables immediate, automated quality decisions - safeguarding blood components from donor to patient, from "vein to vein".
The QTA Tracer can be paired with an individual blood product to provide real-time monitoring and traceability. The system monitors temperature every minute and can also record changes in movement and light.
One of its most innovative features is automatic Shelf-Life Management. Using stability data for the particular blood component being monitored, the system continuously calculates its remaining shelf life and can provide an immediate visual indication of its status. A green indicator shows that the product remains suitable for use according to the configured parameters, while a red indication highlights that the product requires review or may need to be discarded.
This provides healthcare teams with greater visibility of what has happened to a blood product during transportation and handling – helping to eliminate uncertainty, support patient safety and reduce unnecessary blood wastage.
BloodMove + QTA Tracer: A Powerful Combination
By bringing Polar BloodMove and Tridentify technology together, we are exploring an exciting approach to blood transportation: protecting the blood while simultaneously monitoring and documenting its journey.
Our BloodMove solutions provide the specialist temperature-controlled transportation system, while the QTA Tracer System® provides an additional layer of intelligent monitoring, traceability and shelf-life information.
Together, the technologies have the potential to help healthcare organisations gain greater confidence in their blood cold chain while improving efficiency and reducing avoidable waste.
Meet Polar BloodMove & Tridentify at BBTS 2026
We are excited to be exhibiting alongside Tridentify at BBTS 2026 in Glasgow from 15th–17th September.
Visitors will have the opportunity to meet both teams, explore the Polar BloodMove range and discover how the QTA Tracer System® can provide real-time monitoring and intelligent Shelf-Life Management for blood and transfusion products.
We look forward to demonstrating how innovative transportation and monitoring technologies can work together to help safeguard blood throughout its journey.
Visit us at BBTS 2026 and discover the future of smarter blood transportation.